DYN- Dyne Therapeutics, Inc.

Name: Dyne Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Dyne Therapeutics, Inc. (DYN) has 7 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. DYN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Kersten Dirk	5.28M	$136.53M	-
Dir	Rhodes Jason P	4.10M	$106.08M	-
CEO	Cox John	368.2K	$9.53M	-
Other	Kerr Douglas	169.2K	$4.38M	-
Other	Friedl-Naderer Johanna	154.2K	$3.99M	-

Activity

Buys and sells only

Transactions

10 filings · page 16

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 12, 2022	Atlas Venture Opportunity Fund Ii, L.P.	10% Owner	Buy	934,581	$10.70	$10,000,016.70	New	+13.1%	-5.9%
Dec 12, 2022	Rhodes Jason P76	Director	Buy	934,581	$10.70	$10,000,016.70	New	+13.1%	-5.9%
Dec 12, 2022	Beskrovnaya Oxana58	Chief Scientific Officer	Sell	680	$10.87	$7,391.60	-0.7%	+13.1%	-5.9%
Dec 12, 2022	Scalzo Richard William58	See Remarks	Sell	312	$10.87	$3,391.44	-0.6%	+13.1%	-5.9%
Dec 12, 2022	McNeill Jonathan55	See Remarks	Sell	472	$10.87	$5,130.64	-0.5%	+13.1%	-5.9%
Dec 12, 2022	High Susanna Gatti66	Chief Operating Officer	Sell	751	$10.87	$8,163.37	-0.7%	+13.1%	-5.9%
Dec 12, 2022	Farwell Wildon55	Chief Medical Officer	Sell	628	$10.87	$6,826.36	-0.6%	+13.1%	-5.9%
Dec 12, 2022	Brumm Joshua T54	See Remarks	Sell	3,322	$10.87	$36,110.14	-1.0%	+13.1%	-5.9%
Oct 10, 2022	Brumm Joshua T54	See Remarks	Sale+OE	210,000	$12.52	$2,629,522.00	-33.9%	-9.3%	-28.8%
Mar 11, 2022	Scalzo Richard William58	See Remarks	Sell	308	$8.73	$2,688.84	-1.1%	-38.6%	+49.8%

← PrevPage 16Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC